Table 1 Anthropometric measurements and laboratory findings among the study participants
Characteristics | Controls (n = 50) | Patients (n = 100) | p-value (< 0.05) is significant | Significance |
|---|---|---|---|---|
miRNA-33a | 0.0874 ± 0.08755 | 0.0037 ± 0.009579 | < 0.001 | HS |
miRNA- 122 | 1.9615 ± 2.62465 | 3.938774 ± 3.938774 | 0.0016 | HS |
Age (years) | 47.4 ± 4.2046 | 48.4571 ± 8.06350 | < 0.001 | HS |
Sex (male/female) | F 75% M 25% | F 85% M 15% | – – | |
BMI (kg/m2) Normal weight ≥18–< 25 Overweight ≥25–< 30 Obese ≥30 | 24.865 ± 6.1954 Normal (no = 22) (44%) Overweight (no = 28) (56%) | 34.57 ± 5.01458 Overweight (n = 30) (30%) Obese (n = 70) (70%) | < 0.001 | HS |
FBG (mg/dL) | 114.8 ± 47.02168 | 189.878 ± 66.9303 | 0.0140 | HS |
HbA1c (%) | 5.3 ± 0.433669 | 8.47575 ± 1.766534 | 0.0469 | HS |
TC (mg/dL) | 172.15 ± 50.2103 | 203.7273 ± 44.2141 | =0.0115 | HS |
TG (mg/dL) | 133.8 ± 58.01869 | 178.3636 ± 74.463 | =0.0286 | HS |
cHDL (mg/dL) | 42.5697 ± 9.78827 | 40.4 ± 8.987711 | =0.0394 | HS |
cLDL (mg/dL) | 100.86 ± 42.86601 | 125.803 ± 38.72177 | =0.0211 | HS |